Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1998

View Archived Issues

Leprovac: the first commercially available leprosy vaccine

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

Moxifloxacin: possible treatment for S. pneumoniae meningitis

Sheffield and Elan finalize pulmonary drug delivery collaboration

CGP-56697 found to be a safe treatment for uncomplicated falciparum malaria in children

New hope for eliminating mother-to-child transmission of HIV

RADARS study establishes efficacy and safety of Diastat

Millennium, Wyeth-Ayerst discover gene target for CNS disorders

Profile of Lilly's LY-333334, a biosynthetic PTH for inducing bone regeneration

Iomed and Novartis to discontinue research collaboration

RS-980400: a bone-selective vitamin D analogue with bone anabolic effects

Japanese investigators study HIV protease inhibitor with activity in drug-resistant virus

Lodenosine phase I data supports combination studies

Caspase inhibitors in development at Warner-Lambert

Adenosine derivatives useful for CNS and cardiovascular disorders

Immunosuppressive potassium channel blockers from Merck & Co.

Cor Therapeutics patents novel factor Xa inhibitors

Compounds for dopaminergic disorders discovered at American Home Products

AMD-3465, a selective CXCR4 antagonist with potent anti-HIV activity

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

Fujisawa identifies novel ACAT inhibitor series, selects development candidate

MX-68: mechanisms underlying antiinflammatory activity

New peristaltic stimulant on the way to market in Japan

Mechanism of action of new antiarthritic drug KE-298

Clinical trial results in RA reported for T-614